logo Click here for the Department of Medicine Home Page Click here for the UC Irvine Home Page Click here for the School of Medicine Home Page
 
 
 
 

2019 GI Symposium Presentations

The 11th annual Gastroenterology & Hepatology Symposium, held Feb. 22-23 in Anaheim, features the following presentations by faculty members of the UCI Health H.H. Chao Comprehensive Digestive Disease Center (CDDC), as well as our honored guest speakers.

Feb. 22, 2019

Session I — Foregut Diseases: Surgery & Endoscopy

8:15–8:30 a.m.
Endoscopic GERD therapy — ready for primetime?
Jason Samarasena, MD, UCI School of Medicine

8:35–8:50 a.m.
Surgical advances in obesity medicine
Brian Smith, MD, UCI School of Medicine

8:55–9:10 a.m.
New approaches in achalasia and gastroparesis
Robert H. Lee, MD, UCI School of Medicine

9:15–9:45 a.m.
EMR, ESD and beyond
Peter Draganov, MD, University of Florida College of Medicine

Session II — Pancreas & Biliary

12:15–12:30 p.m.
Strategies to minimize risk of ERCP complications
John G. Lee, MD, UCI School of Medicine

12:35 –12:50 p.m.
What's new in interventional EUS?
Kenneth J. Chang, MD, UCI School of Medicine

12:55–1:10 p.m.
Safe pancreas surgery in 2019
Ronald Wolf, MD, UCI School of Medicine

Session III — Colorectal

2:50–3:10 p.m.
The promise of artificial intelligence for colonoscopy quality & documentation
William Karnes, MD, UCI School of Medicine

4:10–4:30 p.m.
Transanal surgery for rectal tumors: What is the role?
Matthew T. Brady, MD, UCI School of Medicine

4:30–4:50 p.m.
Lynch syndrome: in your face but lost in space!
Kathryn Singh, MPH, MS, LCGC, UCI School of Medicine

4:50–5:10 p.m.
Defining colonoscopy quality and why it matters
Caroll Koscheski, MD, Gastroenterology Associates, Hickory, N.C.

Feb. 23, 2019

Session IV — Hepatology

8:30–8:55 a.m.
Overview of the clinical trial data on non-alcoholic steatohepatitis (NASH)
Brent Tetri, MD, Saint Louis University

9–9:25 a.m.
An update on HBV treatment
Daryl T. Lau, MD, Harvard Medical School

9:30–9:55 a.m.
Update on HCV treatment
Douglas Nguyen, MD, UCI School of Medicine

10:30–10:55 a.m.
Overview of autoimmune liver diseases
John Vierling, MD, Baylor College of Medicine

10:55–11:20 a.m.
Workup on liver lesions, benign tumor or HCC
Zeljka Jutric, MD, UCI School of Medicine

Session V — Inflammatory Bowel Disease

1:10–1:35 p.m.
Choosing and positioning biologic therapy for Crohn's disease: (Still) looking for the crystal ball
Siddharth Singh, MD, UC San Diego School of Medicine

1:40–2:05 p.m.
J Pouch in Crohn's disease: Should it be offered? Pros and cons
Steven Mills, MD, and Dorna Jafari, MD, UCI School of Medicine

2:10–2:35 p.m.
Abdominal surgery in the era of biologic therapy: What are the guidelines?
Matthew T. Brady, MD, UCI School of Medicine

2:40–3:05 p.m. 
Case discussions for de-escalation of therapy in IBD
Sandra Park, MD, UCI School of Medicine

3:10–3:35 p.m.
Dysplasia guidelines: Clearing up the confusion
Nimisha Parekh, MD, UCI School of Medicine


View presentations from the 2018 symposium ›